Helen of Troy Limited (HELE)
Should Value Investors Buy Helen of Troy (HELE) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Wall Street Analysts See a 28.41% Upside in Helen of Troy (HELE): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 28.4% in Helen of Troy (HELE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
HELE vs. EL: Which Stock Is the Better Value Option?
Investors interested in Cosmetics stocks are likely familiar with Helen of Troy (HELE) and Estee Lauder (EL). But which of these two companies is the best option for those looking for undervalued stocks?
Are Investors Undervaluing Helen of Troy (HELE) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
HELE or EL: Which Is the Better Value Stock Right Now?
Investors interested in Cosmetics stocks are likely familiar with Helen of Troy (HELE) and Estee Lauder (EL). But which of these two stocks presents investors with the better value opportunity right now?
Is Helen of Troy (HELE) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
HELE Tops Q3 Earnings Estimates, Narrows Sales & Profit Guidance
Helen of Troy's Q3 results reflect a tough consumer spending landscape. While Home & Outdoor unit sales increase, Beauty & Wellness sales decline.
Helen of Troy Plummets Again: Another Speculative Entry
Helen of Troy Limited's fiscal Q3 results showed mixed performance, with growth in Home & Outdoor but weakness in Beauty & Wellness, leading to a cautious outlook. Despite a miss on sales, gross margins improved, and adjusted EPS beat estimates, but free cash flow and operating margins are under pressure. The revised fiscal 2025 outlook, with lowered guidance and higher leverage ratios, triggered a selloff, presenting a speculative buying opportunity at current levels.
Helen of Troy Limited (HELE) Q3 2025 Earnings Call Transcript
Helen of Troy Limited (NASDAQ:HELE ) Q3 2025 Earnings Conference Call January 8, 2025 9:00 AM ET Company Participants Sabrina McKee - Senior Vice President of Investor Relations and Business Development Noel Geoffroy - Chief Executive Officer Brian Grass - Chief Financial Officer Conference Call Participants Robert Labick - CJS Securities Peter Grom - UBS Rupesh Parikh - Oppenheimer & Company Olivia Tong - Raymond James Susan Anderson - Canaccord Genuity Operator Greetings. Welcome to Helen of Troy Limited Third Quarter 2025 Earnings Call.
OXO Parent Helen of Troy Stock Falls as It Lowers Profit Forecast
Shares of Helen of Troy Limited (HELE) fell 4% Wednesday when the maker of household and beauty products reported a drop in quarterly sales and lowered its full-year profit guidance on falling demand for beauty and wellness items.
Compared to Estimates, Helen of Troy (HELE) Q3 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Helen of Troy (HELE) give a sense of how the business performed in the quarter ended November 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Helen of Troy (HELE) Surpasses Q3 Earnings and Revenue Estimates
Helen of Troy (HELE) came out with quarterly earnings of $2.67 per share, beating the Zacks Consensus Estimate of $2.61 per share. This compares to earnings of $2.79 per share a year ago.
